APA (7th ed.) Citation

J, Z., J, B., C, G., J, W., Y, C., J, Z., & H, X. (2023). Serine-associated one-carbon metabolic reprogramming: A new anti-cancer therapeutic strategy. Frontiers in oncology, 13, 1184626. https://doi.org/10.3389/fonc.2023.1184626

Chicago Style (17th ed.) Citation

J, Zhang, Bai J, Gong C, Wang J, Cheng Y, Zhao J, and Xiong H. "Serine-associated One-carbon Metabolic Reprogramming: A New Anti-cancer Therapeutic Strategy." Frontiers in Oncology 13 (2023): 1184626. https://doi.org/10.3389/fonc.2023.1184626.

MLA (9th ed.) Citation

J, Zhang, et al. "Serine-associated One-carbon Metabolic Reprogramming: A New Anti-cancer Therapeutic Strategy." Frontiers in Oncology, vol. 13, 2023, p. 1184626, https://doi.org/10.3389/fonc.2023.1184626.